SPERO THERAPEUTICS INC SPRO
COM · Common Stock · CUSIP 84833T103
Company in Cambridge, United States
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersCambridge, MA
- Websitesperotherapeutics.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 54.0m as of 2024-08-01, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $1.30. Options: 4 managers hold calls ($14.1k notional), 3 hold puts ($1.3k).
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 62 |
| Q1 2020 | 61 |
| Q2 2020 | 81 |
| Q3 2020 | 79 |
| Q4 2020 | 89 |
| Q1 2021 | 96 |
| Q2 2021 | 90 |
| Q3 2021 | 88 |
| Q4 2021 | 85 |
| Q1 2022 | 101 |
| Q2 2022 | 80 |
| Q3 2022 | 70 |
| Q4 2022 | 61 |
| Q1 2023 | 49 |
| Q2 2023 | 57 |
| Q3 2023 | 55 |
| Q4 2023 | 51 |
| Q1 2024 | 55 |
| Q2 2024 | 49 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2022 | 25 | 43 |
| Q4 2022 | 24 | 40 |
| Q1 2023 | 18 | 20 |
| Q2 2023 | 21 | 17 |
| Q3 2023 | 17 | 21 |
| Q4 2023 | 15 | 18 |
| Q1 2024 | 23 | 19 |
| Q2 2024 | 17 | 19 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2023 | $0 | $72.6k | — |
| Q4 2023 | $0 | $29.4k | — |
| Q1 2024 | $59.9k | $0 | 0.00 |
| Q2 2024 | $14.1k | $1.3k | 0.09 |
Biggest buyers
| CITADEL ADVISORS LLC | New | +312.0k |
| ACADIAN ASSET MANAGEMENT LLC | Added | +309.3k |
| RENAISSANCE TECHNOLOGIES LLC | Added | +121.5k |
| VANGUARD GROUP INC | Added | +117.1k |
| TWO SIGMA SECURITIES, LLC | New | +67.7k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | +23.1k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +22.7k |
| BlackRock Inc. | Added | +6.5k |
| MACKENZIE FINANCIAL CORP | Added | +4.3k |
| Cullen/Frost Bankers, Inc. | New | +2.0k |
Biggest sellers
| Shay Capital LLC | Reduced | -282.0k |
| Man Group plc | Reduced | -140.6k |
| BANK OF MONTREAL /CAN/ | Sold out | -79.5k |
| Squarepoint Ops LLC | Sold out | -79.4k |
| Atlas Venture Life Science Advisors, LLC | Reduced | -72.3k |
| BAILARD, INC. | Sold out | -60.9k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -49.4k |
| GSA CAPITAL PARTNERS LLP | Sold out | -28.3k |
| PRUDENTIAL FINANCIAL INC | Sold out | -25.4k |
| Virtu Financial LLC | Sold out | -18.2k |
Biggest calls
| GROUP ONE TRADING LLC | Unchanged | $8.4k6.5k shares |
| SIMPLEX TRADING, LLC | Reduced | $5.0k4.6k shares |
| CITADEL ADVISORS LLC | New | $650500 shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| CITADEL ADVISORS LLC | New | $1.3k1.0k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
| SIMPLEX TRADING, LLC | New | $0100 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| GSK plc 13D · may seek influence filed 2025-03-28 | 16.4% |
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2022 | 0 | — | 1 | $5.4k | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 4 | $45.9k | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 0 | — | 5 | $69.3k | $7.7k |
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 5 | $318.0k | $107.7k |
| Q2 2024 | 0 | — | 0 | — | — |
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| Anson Funds Management LP 0.70% of their portfolio | 3.8m $4.9m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 1.8m $2.3m | Added +117.1k |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 1.1m $1.4m | Added +309.3k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 976.0k $1.3m | Added +121.5k |
| ADAR1 Capital Management, LLC 0.24% of their portfolio | 918.9k $1.2m | Reduced -8.0k |
| Alphabet Inc. 0.06% of their portfolio | 890.0k $1.2m | Unchanged |
| Murchinson Ltd. 0.24% of their portfolio | 873.9k $1.1m | Unchanged |
| Atlas Venture Life Science Advisors, LLC 0.07% of their portfolio | 535.3k $695.9k | Reduced -72.3k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 492.2k $640.0k | Added +22.7k |
| BlackRock Inc. 0.00% of their portfolio | 483.4k $628.4k | Added +6.5k |
| NOVO HOLDINGS A/S 0.03% of their portfolio | 468.9k $609.6k | Unchanged |
| AWM Investment Company, Inc. 0.06% of their portfolio | 333.4k $433.4k | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 312.0k $405.6k | New |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 184.8k $240.2k | Unchanged |
| STATE STREET CORP 0.00% of their portfolio | 130.5k $169.7k | Unchanged |
| DAFNA Capital Management LLC 0.04% of their portfolio | 125.0k $162.5k | Unchanged |
| NORTHERN TRUST CORP 0.00% of their portfolio | 112.3k $146.0k | Reduced -2.3k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 98.5k $128.1k | Reduced -49.4k |
| Man Group plc 0.00% of their portfolio | 73.5k $95.5k | Reduced -140.6k |
| TWO SIGMA SECURITIES, LLC 0.00% of their portfolio | 67.7k $88.0k | New |
| MACKENZIE FINANCIAL CORP 0.00% of their portfolio | 32.7k $42.5k | Added +4.3k |
| DLK Investment Management, LLC 0.02% of their portfolio | 31.4k $40.8k | Unchanged |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 28.6k $37.1k | Unchanged |
| Shay Capital LLC 0.01% of their portfolio | 25.0k $32.5k | Reduced -282.0k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 23.1k $30.0k | New |
| Three Seasons Wealth, LLC 0.01% of their portfolio | 15.0k $19.5k | Unchanged |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 10.0k $13.0k | Unchanged |
| Texas Yale Capital Corp. 0.00% of their portfolio | 10.0k $13.0k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 7.0k $9.1k | Reduced -16.7k |
| Russell Investments Group, Ltd. 0.00% of their portfolio | 6.4k $8.3k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 5.6k $7.2k | Added +366 |
| FMR LLC 0.00% of their portfolio | 2.9k $3.8k | Added +500 |
| WR Wealth Planners, LLC 0.00% of their portfolio | 2.6k $3.4k | Unchanged |
| Cullen/Frost Bankers, Inc. 0.00% of their portfolio | 2.0k $2.6k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 2.0k $3.0k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 1.0k $1.3k | Added +460 |
| Allworth Financial LP 0.00% of their portfolio | 600 $840 | Unchanged |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 472 $614 | Unchanged |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 458 $595 | Unchanged |
| UBS Group AG 0.00% of their portfolio | 331 $430 | Reduced -5.4k |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 295 $384 | Added +248 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 276 $359 | Added +60 |
| CoreCap Advisors, LLC 0.00% of their portfolio | 192 $250 | Added +50 |
| US BANCORP \DE\ 0.00% of their portfolio | 151 $196 | Unchanged |
| NewEdge Advisors, LLC 0.00% of their portfolio | 100 $130 | Unchanged |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 30 $39 | Unchanged |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 12 $16 | Unchanged |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 1 $1 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |